Ozempic, Mounjaro, and Zepbound can drive impressive weight loss, but stopping them is often followed by rapid weight regain. Researchers found that people regain weight faster after quitting these ...

Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...

Hair loss has long confounded the pharmaceutical industry, but there’s hope on the horizon. Veradermics has announced success in its late-stage clinical trial with a drug to reverse hair loss. The ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump. The biotech company will also offer the first hearing-loss gene therapy for free to ...

Kailera Therapeutics is taking a somewhat unusual step in its effort to bring a new weight-loss drug to market. One of its phase 3 studies of ribupatide will test the dual GLP-1/glucose-dependent ...

Amazon is rolling out a new GLP‑1 program aimed at simplifying access to popular weight-loss drugs, from doctor visits to prescription delivery. The company announced on April 21 that Amazon One ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. As GLP‑1 weight‑loss drugs move into the medical mainstream, experts ...